Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection
Lawrence Corey(Fred Hutch Cancer Center), for the Chiron HSV Vaccine Study Group, H. Hunter Handsfield(University of Washington), Wai Yie Leong(INTI International University), Adaora A. Adimora(Office of Infectious Diseases), Rose E. Sekulovich, Richard P. DiCarlo, Allen Izu, Andria Langenberg, Lisa Marr, Rae Lyn Burke(Agenus (United States)), John M. Douglas, Stephen E. Straus(Toronto Public Health), Rhoda L. Ashley, Peter A. Leone(Office of Infectious Diseases), Stephen K. Tyring(Center for Clinical Studies), Terri Warren, Cornelia L. Dekker(Palo Alto University)
Cited by 487
Related Papers
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
|PsycEXTRA Dataset|2006|3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Recommendations for the Management of Herpes Zoster
|Clinical Infectious Diseases|2006|842